Wolverine Asset Management LLC Nektar Therapeutics Transaction History

Wolverine Asset Management LLC

  • $6.43 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$15.77 - $19.03 $403,506 - $486,920
-25,587 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$16.59 - $24.79 $387,459 - $578,970
23,355 Added 1046.37%
25,587 $424,000
Q2 2020

Aug 13, 2020
BUY
$16.86 - $23.44 $37,631 - $52,318
2,232 New
2,232 $51,000

Others Institutions Holding NKTR

# of Institutions
19
Shares Held
15.6M
Call Options Held
0
Put Options Held
0
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $10.6B
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email